Granted Patent
B2
US 7,476,684 · App. 11/523,717 · Granted Jan 13, 2009
Compounds for the treatment of neurological, psychiatric or pain disorders
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
Claims (6)
1. A compound of formula II
as well as a pharmaceutically acceptable salt thereof.
2. A compound according to claim 1 in crystalline form.
3. The compound 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride.
4. The compound 4-(5- {(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H- 1,2,4-triazol-3-yl)pyridine sulphate.
5. A pharmaceutical composition comprising a compound according to any one of claims 1 , 2 , 3 or 4 as an active ingredient, together with a pharmacologically and pharmaceutically acceptable carrier.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 25, 2007
From: NPS PHARMACEUTICALS, INC.; ASTRAZENECA AB
To: ASTRAZENECA AB
Reel/Frame 020045/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 15, 2007
From: MINIDIS, ALEXANDER; WENSBO, DAVID; ISAAC, METHVIN; SLASSI, ABDELMALIK; ARORA, JALAJ; XIN, TAO; EDWARDS, LOUISE; ERIKSSON, CAROLINE; PROFIR, VERONICA; BERGSTROM, PER-OLOV
To: ASTRAZENECA AB; NPS PHARMACEUTICALS, INC.
Reel/Frame 018895/0476 →